DK43676A - Fremgangsmade til fremstilling af et cytotoksisk middel - Google Patents
Fremgangsmade til fremstilling af et cytotoksisk middelInfo
- Publication number
- DK43676A DK43676A DK43676*#A DK43676A DK43676A DK 43676 A DK43676 A DK 43676A DK 43676 A DK43676 A DK 43676A DK 43676 A DK43676 A DK 43676A
- Authority
- DK
- Denmark
- Prior art keywords
- preparation
- cytotoxic agent
- cytotoxic
- agent
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K39/44—Antibodies bound to carriers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
- A61K47/6835—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site
- A61K47/6883—Polymer-drug antibody conjugates, e.g. mitomycin-dextran-Ab; DNA-polylysine-antibody complex or conjugate used for therapy
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Immunology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Peptides Or Proteins (AREA)
- Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)
- Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
- Medicinal Preparation (AREA)
- Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB4695/75A GB1496011A (en) | 1974-11-22 | 1975-02-04 | Defoaming composition |
Publications (1)
Publication Number | Publication Date |
---|---|
DK43676A true DK43676A (da) | 1976-08-05 |
Family
ID=9782062
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK43676*#A DK43676A (da) | 1975-02-04 | 1976-02-03 | Fremgangsmade til fremstilling af et cytotoksisk middel |
Country Status (5)
Country | Link |
---|---|
JP (1) | JPS51126281A (da) |
BE (1) | BE838273A (da) |
DK (1) | DK43676A (da) |
NL (1) | NL7601132A (da) |
SE (1) | SE7601125L (da) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS57143326A (en) * | 1981-03-03 | 1982-09-04 | Teijin Ltd | Polymer linked to cellular toxic substance and its preparation |
DE3205847A1 (de) * | 1981-05-08 | 1982-12-16 | Farmitalia Carlo Erba S.p.A., 20159 Milano | Daunorubicinprotein-konjugate |
JPS60172935A (ja) * | 1984-02-16 | 1985-09-06 | Green Cross Corp:The | 制癌作用物質複合体の製造方法 |
JPS611622A (ja) * | 1984-06-14 | 1986-01-07 | Teijin Ltd | 細胞毒性複合体及びその製造法 |
FR2586564B1 (fr) * | 1985-09-04 | 1989-04-07 | Pierre Tran Ba Loc | Composes immuno-suppresseurs et leur procede de preparation |
JPS62228025A (ja) * | 1985-12-27 | 1987-10-06 | Teijin Ltd | 抗体複合体の製造方法 |
JPH0662438B1 (da) * | 1986-08-28 | 1994-08-17 | Teijin Ltd | |
DE3788058T2 (de) * | 1986-08-28 | 1994-04-21 | Teijin Ltd | Zelltoxischer antikörperkomplex und verfahren zu seiner herstellung. |
US5149782A (en) * | 1988-08-19 | 1992-09-22 | Tanox Biosystems, Inc. | Molecular conjugates containing cell membrane-blending agents |
JP2626654B2 (ja) * | 1990-03-31 | 1997-07-02 | 科学技術振興事業団 | 標的指向性高分子医薬化合物及びその中間体 |
-
1976
- 1976-02-03 SE SE7601125A patent/SE7601125L/ not_active Application Discontinuation
- 1976-02-03 JP JP51010786A patent/JPS51126281A/ja active Pending
- 1976-02-03 DK DK43676*#A patent/DK43676A/da not_active Application Discontinuation
- 1976-02-04 NL NL7601132A patent/NL7601132A/xx not_active Application Discontinuation
- 1976-02-04 BE BE164096A patent/BE838273A/fr unknown
Also Published As
Publication number | Publication date |
---|---|
BE838273A (fr) | 1976-08-04 |
NL7601132A (en) | 1976-08-06 |
JPS51126281A (en) | 1976-11-04 |
SE7601125L (sv) | 1976-08-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK113676A (da) | Fremgangsmade til fremstilling af et retardpreparat | |
DK151013C (da) | Analogifremgangsmaade til fremstilling af 5-methyl-isoxazol-4-carboxylsyreanilider | |
DK567376A (da) | Fremgangsmade til fremstilling af quinazolonderivater | |
DK113476A (da) | Fremgangsmade til fremstilling af amoxicillintrihydrat | |
DK107876A (da) | Fremgangsmade til fremstilling af thiocarbamider | |
DK43676A (da) | Fremgangsmade til fremstilling af et cytotoksisk middel | |
DK324176A (da) | Fremgangsmade til fremstilling af orthoaminobutyrophenonderivater | |
DK528976A (da) | Fremgangsmade til fremstilling af indazolderivater | |
DK298476A (da) | Fremgangsmade til fremstilling af 5-benzyl-2-oxazolidonderivater | |
DK150676A (da) | Fremgangsmade til fremstilling af krystallinsk natrium-o-formyl-cefamandol | |
DK137275C (da) | Fremgangsmaade til fremstilling af 4-oxo-hexahydropyrazinoisoquinolinderivater | |
DK531676A (da) | Fremgangsmade til fremstilling af ethylaminderivater | |
DK565676A (da) | Fremgangsmade til fremstilling af klavamderivater | |
DK127976A (da) | Fremgangsmade til fremstilling af thiazolinonderivater | |
DK343976A (da) | Fremgangsmade til fremstilling af 5-androsten-17-on-derivater | |
DK551076A (da) | Fremgangsmade til fremstilling af trifluormethylthio-derivater af cyproheptadin | |
DK251176A (da) | Fremgangsmade til fremstilling af cyklopropanolderivater | |
DK253676A (da) | Fremgangsmade til fremstilling af cycloheptathiopenderivater | |
DK141532C (da) | Fremgangsmaade til fremstilling af 21-hydroxy-16-pregnen-20-onderivater | |
DK141584C (da) | Fremgangsmaade til fremstilling af slagseje vinylaromat-podecopolymere | |
DK480676A (da) | Fremgangsmade til fremstilling af s-alkylphosphordihalogeniddithioater | |
DK263076A (da) | Fremgangsmade til fremstilling af et antigent middel | |
DK142280C (da) | Fremgangsmaade til fremstilling af 4-aminopyridiner | |
DK62876A (da) | Fremgangsmade til fremstilling af benzo-cyclohepta-thiophenderivater | |
DK562076A (da) | Fremgangsmade til fremstilling af azetidinonderivater |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AHB | Application shelved due to non-payment |